SCHEMBL574469

SCHEMBL574469

Nc1[c]cc(N2CCOCC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LGMN Q99538 3/20 0.50
MAPT P10636 6/20 0.47
ALDH1A1 P00352 5/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
HTT P42858 2/20 0.47
CYP1A2 P05177 1/20 0.47
LMNA P02545 1/20 0.47
ALOX15 P16050 3/20 0.46
HSD17B10 Q99714 3/20 0.46
TP53 P04637 3/20 0.46
KDM4E B2RXH2 3/20 0.46
USP2 O75604 1/20 0.46
MAPK1 P28482 1/20 0.46
HPGD P15428 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
PKM P14618 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9213288 0.82 ALDH1A1 (0.50) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL574835 0.78 MAPT (0.58) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL23166136 0.78 ALDH1A1 (0.47) LGMNMAPTALDH1A1MEN1KMT2A
SCHEMBL9093746 0.77 LMNA (0.71) LGMNMAPTALDH1A1MEN1KMT2A
SCHEMBL20631 0.76 MAPT (0.61) LGMNMAPTALDH1A1MEN1KMT2A
SCHEMBL20631313 0.74 LMNA (0.61) LGMNMAPTALDH1A1MEN1KMT2A
Hydrochloric Acid SCHEMBL16209945 0.74 MAPT (0.65) LGMNMAPTALDH1A1MEN1KMT2A
SCHEMBL21596383 0.74 GAA (0.62) MAPTMEN1KMT2ALMNAKDM4E
SCHEMBL3605536 0.74 MAPT (0.46) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL27908896 0.73 LGMN (0.53) LGMNMAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8987267-B2 2-substituted-8-alkyl-7-OXO-7,8-dihydropyrido[2,3-D]pyrimidine-6-carbonitriles and uses thereof in treating proliferative disorders Temple University—Of the Commonwealth System of Higher Education (US) 2015-03-24 US claimed
EP-2600719-B1 2-SUBSTITUTED-8-ALKYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBONITRILES AND USES THEREOF UNIV TEMPLE (US) 2014-10-08 EP claimed
EP-2600719-A1 2-SUBSTITUTED-8-ALKYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBONITRILES AND USES THEREOF Temple University - Of The Commonwealth System of Higher Education (US) 2013-06-12 EP claimed
US-20130131058-A1 2-SUBSTITUTED-8-ALKYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D] PYRIMIDINE-6-CARBONITRILES AND USES THEREOF TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2013-05-23 US claimed
WO-2012018540-A1 2-SUBSTITUTED-8-ALKYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D] PYRIMIDINE-6-CARBONITRILES AND USES THEREOF TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2012-02-09 WO claimed
CN-108264511-B Heterocyclic derivative, preparation method thereof and application thereof in medicine 浙江海正药业股份有限公司 2021-04-13 CN disclosed
US-8987267-B2 2-substituted-8-alkyl-7-OXO-7,8-dihydropyrido[2,3-D]pyrimidine-6-carbonitriles and uses thereof in treating proliferative disorders Temple University—Of the Commonwealth System of Higher Education (US) 2015-03-24 US disclosed
EP-2600719-B1 2-SUBSTITUTED-8-ALKYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBONITRILES AND USES THEREOF UNIV TEMPLE (US) 2014-10-08 EP disclosed
EP-2600719-A1 2-SUBSTITUTED-8-ALKYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBONITRILES AND USES THEREOF Temple University - Of The Commonwealth System of Higher Education (US) 2013-06-12 EP disclosed
US-20130131058-A1 2-SUBSTITUTED-8-ALKYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D] PYRIMIDINE-6-CARBONITRILES AND USES THEREOF TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2013-05-23 US disclosed
WO-2012018540-A1 2-SUBSTITUTED-8-ALKYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D] PYRIMIDINE-6-CARBONITRILES AND USES THEREOF TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2012-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131058-A1 2-SUBSTITUTED-8-ALKYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D] PYRIMIDINE-6-CARBONITRILES AND USES THEREOF CDK7, CDK2, CDK8 LGMN 3422/4885MAPT 4742/4885ALDH1A1 1218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.